We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Platelet Concentration System Optimizes Conditions for Healing

By HospiMedica International staff writers
Posted on 31 Jul 2012
An updated platelet concentration system produces Platelet Rich Plasma (PRP), a blood plasma with highly concentrated platelets that also contain natural growth factors that help optimize conditions for healing.

The Harvest SmartPReP 2 Platelet Concentrate System is designed to produce autologous platelet concentrate enriched with growth factors (APC+) in less than 15 minutes, which can then be used to improve the handling characteristics of graft material, facilitate fixation of graft material to the surgical site, and help optimize conditions for healing. More...
The system is based on self-calibrating, floating shelf technology that automatically optimizes platelet recovery for every patient, and can process as little as 20 cc of whole blood for smaller applications in additional to larger volumes when needed.

The unique automated dual-spin and decanting process, coupled with self-calibrating disposables, makes the system significantly easier to use than more complex systems by using state-of-the-art sensors and controls that maximize platelet recovery while eliminating operator interaction. The floating shelf technology also ensures optimal results independent of patient hematocrit, blood volume processed, or operator, as well as eliminating product weighing or multiple manipulations of blood bags and tests tubes. The Terumo SmartPReP 2 Platelet Concentrate System is a product of Harvest Technologies (Plymouth, MA, USA).

“The SmartPReP 2 System has allowed me to effectively deliver the highest possible concentration of PRP in a simple and sterile system that is extremely easy to use,” said Scott Sondes, MD, a physical medicine and rehabilitation specialist in Covington (LA, USA). “I've treated patients with knee issues and, within two weeks, patients exhibited improvement and demonstrated a high level of function.”

PRP is blood plasma with highly concentrated platelets that can exceed 2 million platelets per micro liter. Seven fundamental protein growth factors are concentrated, including platelet-derived growth factors (PDGFaa, PDGFab, PDGFbb), transforming growth factors (TGFb1, TGFb2), vascular endothelial growth factors (VEGF), and epithelial growth factors (EGF). The concentrate also contains three proteins that act as cell adhesion molecules: fibrin, fibronectin, and vitronectin. Since PRP is autologous, there is no rejection or adverse effects.

Related Links:

Harvest Technologies



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
New
Blood Pressure Monitor
Cuff Blood Pressure Monitor
New
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Six-month FlexPulse IDE data show positive outcomes with Abbott’s TactiFlex Duo catheter, confirming safety and efficacy seen in the CE Mark study for complex AFib (photo courtesy of Abbott)

Dual-Energy Ablation and Conduction System Pacing Show Positive Early Outcomes

Atrial fibrillation and other arrhythmias are common in both hospitalized and ambulatory patients, often complicating hemodynamic stability, stroke prevention, and perioperative care. Within this context,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.